Financials
| Interim Results | Sep. 24, 2024 |
| Final Results | Apr. 23, 2024 |
| Interim Results | Sep. 12, 2023 |
| Final Results | Mar. 09, 2023 |
| Interim Results | Sep. 29, 2022 |
| Final Results | Feb. 23, 2022 |
| Interim Results | Sep. 20, 2021 |
Proxies
| Result of AGM | Jun. 30, 2025 |
| AGM Statement | Jun. 30, 2025 |
| Result of AGM | May. 23, 2024 |
| Posting of Annual Report & Notice of AGM | Apr. 29, 2024 |
| Result of AGM | Apr. 03, 2023 |
| Posting of Annual Report & Notice of AGM | Mar. 09, 2023 |
| Result of AGM | Mar. 24, 2022 |
Ownership Update
| TR-1: Notification of major holdings | May. 23, 2025 |
| Holding(s) in Company | May. 21, 2025 |
| Holding(s) in Company | May. 09, 2025 |
| Holding(s) in Company | Apr. 29, 2025 |
| Holding(s) in Company | Apr. 29, 2025 |
| Holding(s) in Company | Apr. 28, 2025 |
| TR-1: Standard form notification of major holdings | Apr. 23, 2025 |
Announcements
| Change of Registered Address | Apr. 20, 2026 |
| Result of General Meeting and Change of Name | Mar. 17, 2026 |
| Notice of GM and Proposed Change of Name | Feb. 27, 2026 |
| CEO Appointment & Name Change Thalia Therapeutics | Feb. 24, 2026 |
| Partnership with University of Strathclyde’s CMAC | Sep. 23, 2025 |
| N4 Pharma’s Nuvec® Targets Lung Cancer Cells | Sep. 22, 2025 |
| Investor Event and Presentation | Sep. 11, 2025 |